首页> 外文期刊>BMJ Open >Disparities in the receipt of robot-assisted radical prostatectomy: between-hospital and within-hospital analysis using 2009–2011 California inpatient data
【24h】

Disparities in the receipt of robot-assisted radical prostatectomy: between-hospital and within-hospital analysis using 2009–2011 California inpatient data

机译:机器人辅助根治性前列腺切除术的接受率差异:使用2009-2011年加利福尼亚州住院患者数据进行的医院间和医院内分析

获取原文
           

摘要

Objectives Despite the rapid proliferation of robot-assisted radical prostatectomy (RARP), little attention has been paid to patient utilisation of this newest surgical innovation and barriers that may result in disparities in access to RARP. The goal of this study is to identify demographic and economic factors that decrease the likelihood of patients with prostate cancer (PC) receiving RARP. Design, setting and participants A retrospective, pooled, cross-sectional study was conducted using 2009–2011 California State Inpatient Data and American Hospital Association data. Patients who were diagnosed with PC and underwent radical prostatectomy (RP) from 225 hospitals in California were identified, using ICD-9-CM diagnosis and procedure codes. Primary outcome measures Patients’ likelihood of receiving RARP was associated with patient and hospital characteristics using the two models: (1) between-hospital and (2) within-hospital models. Multivariate binomial logistic regression was used for both models. The first model predicted patient access to RARP-performing hospitals versus non-RARP-performing hospitals, after adjusting for patient and hospital-level covariates (between-hospital variation). The second model examined the likelihood of patients receiving RARP within RARP-performing hospitals (within-hospital variation). Results Among 20?411 patients who received RP, 13?750 (67.4%) received RARP, while 6661 (32.6%) received non-RARP. This study found significant differences in access to RARP-performing hospitals when race/ethnicity, income and insurance status were compared, after controlling for selected confounding factors (all p0.001). For example, Hispanic, Medicare and Medicaid patients were more likely to be treated at non-RARP-performing hospitals versus RARP-performing hospitals. Within RARP-performing hospitals, Medicaid patients had 58% lower odds of receiving RARP versus non-RARP (adjusted OR 0.42, p0.001). However, there were no significant differences by race/ethnicity or income within RARP-performing hospitals. Conclusions Significant differences exist by race/ethnicity and payer status in accessing RARP-performing hospitals. Furthermore, payer status continues to be an important predictor of receiving RARP within RARP-performing hospitals.
机译:目的尽管机器人辅助根治性前列腺切除术(RARP)迅速普及,但对于这种最新的外科手术创新和障碍的利用却很少引起患者的注意,因为这可能会导致RARP的获取机会不均。这项研究的目的是确定人口统计学和经济因素,这些因素可降低患有前列腺癌(PC)的患者接受RARP的可能性。设计,环境和参与者使用2009–2011年加利福尼亚州住院患者数据和美国医院协会数据进行了回顾性,汇总,横断面研究。使用ICD-9-CM诊断和程序代码对加利福尼亚州225所医院中诊断为PC并接受了根治性前列腺切除术(RP)的患者进行了鉴定。主要结果指标使用以下两种模型,患者接受RARP的可能性与患者和医院的特征有关:(1)医院间模型和(2)医院内模型。两种模型均使用多元二项式逻辑回归。在对患者和医院水平的协变量(医院之间的差异)进行调整之后,第一个模型可以预测患者进入RARP表现医院与非RARP表现医院的关系。第二个模型检查了在具有RARP表现的医院中患者接受RARP的可能性(医院内差异)。结果20 411例接受RP的患者中,13 750例(67.4%)接受了RARP,而6661例(32.6%)接受了非RARP。这项研究发现,在控制了选定的混杂因素之后,将种族/民族,收入和保险状况进行比较时,进入具有RARP表现的医院的入院率存在显着差异(所有p <0.001)。例如,与非RARP医院相比,西班牙裔,Medicare和Medicaid患者更有可能在非RARP医院接受治疗。在执行RARP的医院中,医疗补助患者接受RARP的几率比未接受RARP的几率低58%(调整后的OR为0.42,p <0.001)。但是,在执行RARP的医院中,种族/民族或收入没有显着差异。结论在访问RARP表现良好的医院时,种族/民族和付款人的身份存在显着差异。此外,付款人的身份仍然是表现良好的RARP医院中接受RARP的重要指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号